Copyright
©The Author(s) 2020.
World J Gastroenterol. Nov 21, 2020; 26(43): 6782-6794
Published online Nov 21, 2020. doi: 10.3748/wjg.v26.i43.6782
Published online Nov 21, 2020. doi: 10.3748/wjg.v26.i43.6782
Figure 4 Lactobacillus bulgaricus regulates the production of tumors proinflammatory cytokines in azoxymethene/dextran sulfate sodium-exposed mice.
Tumor tissues were homogenized and the concentration of TNF-α, IL-6, IL- 1β, IL-17, IFN-γ e IL-23 per gram of tissue (colon) were determined by ELISA (n = 10 mice per group). Results expressed as mean ± SEM. aP < 0.05, bP < 0.01, eP < 0.001 vs controls. Ctrl: Controls; Lb: Lactobacillus bulgaricus.
- Citation: Silveira DSC, Veronez LC, Lopes-Júnior LC, Anatriello E, Brunaldi MO, Pereira-da-Silva G. Lactobacillus bulgaricus inhibits colitis-associated cancer via a negative regulation of intestinal inflammation in azoxymethane/dextran sodium sulfate model. World J Gastroenterol 2020; 26(43): 6782-6794
- URL: https://www.wjgnet.com/1007-9327/full/v26/i43/6782.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i43.6782